Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Katherine E. Poruk

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2170-1688; OpenAlex author ID A5015026500. Sources: OpenAlex.

Their work

Papers
18 (first author 3, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
52
Papers, trials and grants by year

2013: 3 papers · 2014: 1 paper · 2015: 4 papers · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 5 papers

Papers 18

  1. Disparities in Pancreatic Cancer Survival: The Overlooked Role of Demographic and Socioeconomic Factors. Last author DOI 10.1002/jso.70377↗
  2. Factors Associated with Improved Survival for Stage I and II Pancreatic Adenocarcinoma Utilizing the National Cancer Database. Last author DOI 10.1007/s12029-026-01545-4↗
  3. Nationwide Trends in Neoadjuvant Chemotherapy Utilization for Pancreatic Adenocarcinoma From 2012 to 2021. Co-author DOI 10.1016/j.jss.2026.09.037↗
  4. Intraoperative radiation therapy during pancreatectomy for borderline and locally advanced pancreatic cancer: A propensity-matched analysis. Co-author DOI 10.1016/j.surg.2026.110293↗
  5. Redefining Upfront Resectable Pancreatic Ductal Adenocarcinoma: Should Vein Abutment Matter? Co-author DOI 10.6004/jnccn.2025.7097↗
  6. Risk factors in predicting radiologically occult metastatic disease from pancreatic ductal adenocarcinoma: a single-institution experience with routine preoper… Co-author DOI 10.1016/j.gassur.2025.102214↗
  7. Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma. Co-author DOI 10.1200/cci.22.00160↗
  8. Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcin… Co-author DOI 10.1158/1078-0432.ccr-16-1467↗
  9. Primary Tumor Resection Following Favorable Response to Systemic Chemotherapy in Stage IV Pancreatic Adenocarcinoma with Synchronous Metastases: a Bi-instituti… First author DOI 10.1007/s11605-016-3256-2↗
  10. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.1097/sla.0000000000001600↗
  11. What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcinoma? Co-author DOI 10.1007/s11605-014-2740-9↗
  12. Surgery for oligometastasis of pancreatic cancer. First author DOI 10.3978/j.issn.1000-9604.2015.05.02↗
  13. Pancreatic cancer surgery: past, present, and future. First author DOI 10.3978/j.issn.1000-9604.2015.06.07↗
  14. The current state of surgery for pancreatic cancer. Co-author PMID 25651834↗
  15. Screening for pancreatic cancer. Co-author DOI 10.1016/j.yasu.2014.05.004↗
  16. Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e31825e354d↗
  17. Screening for pancreatic cancer: why, how, and who? Co-author DOI 10.1097/sla.0b013e31825ffbfb↗
  18. The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Co-author DOI 10.2174/1566524011313030003↗

Closest collaborators

The 25 strongest of 52 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John Andrew Stauffer · 6 shared papers, 2025–2026 · strength 1.76
  2. Zhi Ven Fong · 4 shared papers, 2026 · strength 1.17
  3. Cornelius A. Thiels · 4 shared papers, 2026 · strength 1.17
  4. Alfredo Verastegui · 3 shared papers, 2025–2026 · strength 0.89
  5. Sibi Krishna Thiyagarajan · 2 shared papers, 2025–2026 · strength 0.59
  6. Matthew John Weiss · 6 shared papers, 2015–2017 · strength 0.40
  7. Matthew A. Firpo · 5 shared papers, 2013–2023 · strength 0.34
  8. Sean J. Mulvihill · 5 shared papers, 2013–2023 · strength 0.34
  9. Jason Pieri · 1 shared paper, 2026 · strength 0.32
  10. Christiana Youssef · 1 shared paper, 2026 · strength 0.30
  11. Christopher Lee Wolfgang · 5 shared papers, 2015–2017 · strength 0.30
  12. Arielle Jacover · 1 shared paper, 2026 · strength 0.29
  13. Michael S. Rutenberg · 1 shared paper, 2026 · strength 0.29
  14. Po Hong Tan · 1 shared paper, 2026 · strength 0.24
  15. Nabil Wasif · 1 shared paper, 2026 · strength 0.24
  16. Richard J. Bold · 1 shared paper, 2026 · strength 0.24
  17. Susanne Gray Warner · 1 shared paper, 2026 · strength 0.24
  18. Chee‐Chee Stucky · 1 shared paper, 2026 · strength 0.24
  19. Michael L. Kendrick · 1 shared paper, 2026 · strength 0.24
  20. Mark Joseph Truty · 1 shared paper, 2026 · strength 0.24
  21. Douglas G. Adler · 3 shared papers, 2013–2023 · strength 0.23
  22. Courtney L. Scaife · 3 shared papers, 2013–2023 · strength 0.22
  23. Josh M. Bleicher · 1 shared paper, 2023 · strength 0.14
  24. Alessandra Rosati · 1 shared paper, 2023 · strength 0.14
  25. Kajsa E. Affolter · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.